Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Cross-sectional study assessing long-term safety of interferon-beta-1b for relapsing-remitting MS.
The role of T cell apoptosis in nervous system autoimmunity.
Effects of an aqueous extract of North American ginseng on MOG((35-55))-induced EAE in mice.
Investigation of the mechanism of action of alemtuzumab in a human CD52 transgenic mouse model.
More to come: humoral immune responses in MS.
B cells and multiple sclerosis.
Selective inhibition of CCR7- TEM cells activation by a novel peptide targeting Kv1.3 in a rat EAE model.
Better Prognosis of Multiple Sclerosis in Patients Who Experienced a Full-Term Pregnancy.
[The first experience of the use the Russian Β-interferon-1b biosimilar (infibeta) in the daily practice of the Moscow Center of Multiple Sclerosis.]
GEMS Project: A Platform to Investigate Multiple Sclerosis Risk.
Tecfidera(®): an approach for repurposing.
The Inaugural Hillel Panitch, MD Multiple Sclerosis Symposium
lambda-Interferons and the single nucleotide polymorphisms: A milestone to tailor-made therapy for chronic hepatitis C.
Genzyme submits applications to FDA and EMA for approval of LEMTRADA™ (alemtuzumab) for multiple sclerosis
Clinical relevance of differential lymphocyte recovery after alemtuzumab therapy for multiple sclerosis.
2-chlorodeoxyadenosine (cladribine) induces apoptosis in human monocyte-derived dendritic cells.
Efficacy and Tolerability of BAF312 in Patients With Polymyositis
Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy.
Intrathecal Therapy With Monoclonal Antibodies in Progressive Multiple Sclerosis (ITT-PMS)
Synthetic Biologics Reports Results of Independent Third Party Evaluations of Trimesta™ Data from Investigator-Sponsored Phase 2 Clinical Trial for Relapsing-Remitting Multiple Sclerosis
Daclizumab discontinue letter for the US market
Magnetic resonance imaging pattern in natalizumab-associated progressive multifocal leukoencephalopathy.
Receptos to Deliver Scientific Presentations Regarding RPC1063 at the 2014 American Academy of Neurology (AAN) Annual Meeting
Immunologic and MRI markers of the therapeutic effect of IFN-β-1a in relapsing-remitting MS.
FTY720/Fingolimod, a Sphingosine Analogue, Reduces Amyloid-β Production in Neurons.

Pages